Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round
Journal of Cancer Research & Clinical Oncology, 04/30/2012
Becker N et al. – The indicated performance indicators fit into the range observed in comparable trials. The study continues finalizing the second screening round and for the first participants even the last screening round. The unresolved issue of the precise amount of side effects and the high early recall rate precludes currently the recommendation of multislice–CT (MSCT) as screening tool for lung cancer.